Clinical Trials Browser

Not yet recruiting × Diabetes Mellitus × 90 days × Clear all

NCT07557914 2026-06-03

Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes

Phase 2 Not yet recruiting

32 enrolled

Gastrointestinal

Diabetes Mellitus, Carcinoma, Hepatocellular

NCT06834204 2026-03-23

ACCESS-PC

Phase NA Not yet recruiting

266 enrolled

GenitourinaryGynecologic

Adenocarcinoma, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypercholesterolemia, Hyperlipidemias, Hypertension, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms